We’re increasing our price target on Bristol Myers after earnings and guidance top forecasts
Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was
Read MoreBristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was
Read MoreBristol Myers Squibb and Pfizer on Thursday said they will start selling their blockbuster blood thinner, Eliquis, directly to patients
Read MoreFILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023.
Read MoreSubscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.